首页> 外国专利> New compounds as telomerase inhibitors that fix the G-quadruplex structure of DNA or RNA, useful in the treatment of cancers

New compounds as telomerase inhibitors that fix the G-quadruplex structure of DNA or RNA, useful in the treatment of cancers

机译:固定端粒酶抑制剂的新化合物,可固定DNA或RNA的G-四链体结构,可用于治疗癌症

摘要

Compounds that fix the G-quadruplex structure of DNA or RNA are new. Compounds that fix the G-quadruplex structure of DNA or RNA and having the formula Ar1-(NR3)p-(CO)n-divider-(CO)m-(NR'3)q-Ar2 (I) are new. n, m, p, and q = 0 or 1; Ar1 = quinoline (optionally substituted by a group N(Ra)(Rb), or 1-4 C alkyl, or alkoxy), quaternized quinoline, benzamidine or pyridine; Ra, Rb = H or 1-4C alkyl; Ar2 = Ar1, a phenyl ring optionally substituted by halogen, alkoxy, CN, carbonyl amino optionally substituted by alkyl, guanyl, alkylthio, amino, alkylamino, dialkylamino, nitro, or alkyleneamino, an aromatic or non-aromatic mono-, bi- or tricyclic heterocycle having 0 - 2 heteroatoms per ring optionally substituted by alkyl, alkylene or alkenylene; R3, R'3 = H or alkyl; divider = triazine (optionally substituted by one or more halogens, alkyl, thio, oxy, or amino, themselves optionally substituted by alkyl), 5 or 6 membered heterocycle containing O, S, or N, phenyl, -NH-phenyl-NH-, NH-phenyl-CH2-NH-, -NH-CH2-phenyl-CH2-NH-, -NH-CH2-phenyl-NH-CH2-phenyl-CH2-, -CH2-phenyl, -phenyl-CH2-, -CH2-thienyl-, -thienyl-CH2-, -CH=CH-, or a diazine, all of these being optionally substituted. With the provisos that: (1) when the divider group is phenyl optionally substituted by CH2, n, m, p, and q = 1, and R3 and R'3 are H, then the nitrogen heterocycle and the aromatic ring are not both unsubstituted quinoline or quinoline substituted on the N atom by 1-6C alkyl; and (2) when the divider group is a triazine and p and q are both 1, then n and m are not both 0.
机译:固定DNA或RNA的G-四链体结构的化合物是新的。固定DNA或RNA的G-四链体结构并具有式Ar1-(NR3)p-(CO)n-除数-(CO)m-(NR'3)q-Ar2(I)的化合物是新的。 n,m,p和q = 0或1; Ar1 =喹啉(任选地被基团N(Ra)(Rb)或1-4个碳原子的烷基或烷氧基取代),季铵化的喹啉,苯甲or或吡啶; Ra,Rb = H或1-4C烷基; Ar 2 = Ar 1,任选地被卤素,烷氧基,CN,羰基氨基取代的苯环,其任选地被烷基,胍基,烷硫基,氨基,烷基氨基,二烷基氨基,硝基或亚烷基氨基取代,是芳族或非芳族的单,双或环烷基。每个环具有0-2个杂原子的三环杂环任选被烷基,亚烷基或亚烯基取代; R3,R'3 = H或烷基;分频器=三嗪(任选地被一个或多个卤素,烷基,硫代,氧基或氨基取代,其本身任选地被烷基取代),5或6元杂环,其包含O,S或N,苯基,-NH-苯基-NH- ,NH-苯基-CH2-NH-,-NH-CH2-苯基-CH2-NH-,-NH-CH2-苯基-NH-CH2-苯基-CH2-,-CH2-苯基,-苯基-CH2-,- CH 2-噻吩基-,-噻吩基-CH 2-,-CH = CH-或二嗪,所有这些均任选被取代。满足以下条件:(1)当分隔基为可被CH2,n,m,p和q = 1任选取代的苯基,且R3和R'3为H时,氮杂环和芳环均不相同未取代的喹啉或在N原子上被1-6C烷基取代的喹啉; (2)当分隔基为三嗪且p和q均为1时,n和m都不均为0。

著录项

  • 公开/公告号FR2825090A1

    专利类型

  • 公开/公告日2002-11-29

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA SA;

    申请/专利号FR20010006909

  • 发明设计人 BOUCHARD HERVE;HITTINGER AUGUSTIN;

    申请日2001-05-28

  • 分类号C07D409/14;C07D401/14;C07D401/12;A61K31/506;A61K31/47;A61P35/00;

  • 国家 FR

  • 入库时间 2022-08-21 23:38:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号